Laboratorial Aspects of Cytolytic Vaginosis and Vulvovaginal Candidiasis as a Key for Accurate Diagnosis: A Pilot Study

Laboratorial Aspects of Cytolytic Vaginosis and Vulvovaginal Candidiasis as a Key for Accurate Diagnosis: A Pilot Study

Abstract Objective To identify clinical, microscopic, and biochemical characteristics that differentiate cytolytic vaginosis (CV) from vulvovaginal candidiasis (VVC). Methods The present cross-sectional study analyzed the vaginal contents of 24 non-pregnant women aged 18 to 42 years who were atten...

Full description

Bibliographic Details
Main Authors:	José Marcos Sanches, Paulo César Giraldo, Marcela Grigol Bardin, Rose Amaral, Michelle Garcia Discacciati, Luana Rossato
Format:	Article
Language:	English
Published:	Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2020-12-01
Series:	Revista Brasileira de Ginecologia e Obstetrícia
Subjects:	cytolytic vaginosis dysbiosis gram stain vaginal bacterioscopy vulvovaginal candidiasis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032020001000634&tlng=en

Similar Items

Bacterial Vaginosis and Vulvovaginal Candidiasis Pathophysiologic Interrelationship
by: Jack D. Sobel, et al.
Published: (2024-01-01)

Prevalence, Associated Factors, and Appropriateness of Empirical Treatment of Trichomoniasis, Bacterial Vaginosis, and Vulvovaginal Candidiasis among Women with Vaginitis
by: Sung-Hsi Huang, et al.
Published: (2023-06-01)

Vulvovaginitis and vaginosis treatment: clinical and laboratory efficiency
by: V N Prilepskaya, et al.
Published: (2013-08-01)

VAGINOSIS CITOLÍTICA: UN DIAGNÓSTICO DIFERENCIAL POCO FRECUENTE DE VULVOVAGINITIS MICÓTICA A REPETICIÓN
by: Paolo Ricci A, et al.
Published: (2010-01-01)

Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis
by: Wenhui Qi, et al.
Published: (2021-11-01)

Recurrent vulvovaginitis and vaginosis. Possibilities of effective therapy
by: Vera N. Prilepskaya, et al.
Published: (2020-11-01)

Experience of using the local combination product containing miconazole and metronidazole for the treatment of bacterial vaginosis and vulvovaginal candidiasis in pregnant women
by: V O Bitsadze, et al.
Published: (2016-12-01)

Prevalence of bacterial vaginosis, candidiasis, trichomoniasis, and associated factors in two hospitals of Apartadó and Rionegro – Antioquia, 2014
by: Valencia-Arredondo, Marleny, et al.
Published: (2018-04-01)

The modern approach to the etiology, pathogenesis, treatment and prevention of bacterial vaginosis and vaginal candidiasis
by: O A Pustotina
Published: (2015-06-01)

Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis
by: Bingbing Xiao, et al.
Published: (2022-03-01)

Association of sanitary pads and clothing with vulvovaginitis
by: Marcela Grigol Bardin, et al.
Published: (2022-03-01)

Vulvovaginitis and the treatment of asymptomatic partners
by: Paulo César Giraldo, et al.
Published: (2022-04-01)

Modern opportunities for the diagnosis and treatment of vulvovaginal candidiasis (in aid of a practitioner)
by: E. R. Dovletkhanova, et al.
Published: (2019-10-01)

Síndrome de flujo vaginal (vaginitis / vaginosis): actualización diagnóstica y terapéutica
by: Franklin De La Hoz Espitia
Published: (2021-07-01)

Natamycin in the treatment of chronic recurrent vulvovaginal candidiasis associated with intestinal candidiasis
by: I. O. Malova, et al.
Published: (2018-09-01)

Bacterial vaginosis
by: Filiz AKATA
Published: (1997-09-01)

Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01)

Prevention of dysbiotic and inflammatory diseases of the vagina and vulva after surgical correction of genital prolapse and stress urinary incontinence
by: Irina A. Lapina, et al.
Published: (2020-12-01)

Risk Factors and Health Hazards of Vaginal Infections in Upper Egypt: A Cross Sectional Study
by: Ahmed M. Abbas, et al.
Published: (2016-03-01)

Livarol in the treatment of chronic vulvovaginal candidiasis
by: Т. С. Дивакова, et al.
Published: (2017-06-01)

The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-06-01)

Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01)

Gram stain and Giemsa stain as a rapid diagnostic tool for diagnosis of vaginal infections” in Western Nepal
by: Kishor Bajracharya, et al.
Published: (2019-05-01)

Differentiated approach to the treatment of various forms of vulvovaginal candidiasis
by: T Yu Pestrikova, et al.
Published: (2014-06-01)

Assesment of Two Different Methods to Diagnose Bacterial Vaginosis
by: Sh. Niroomanesh, et al.
Published: (1998-04-01)

Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy
by: Zhongwen Sun, et al.
Published: (2023-02-01)

Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01)

Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection
by: Yufei Wang, et al.
Published: (2024-03-01)

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
by: Hubertine M.E. Willems, et al.
Published: (2020-02-01)

Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy
by: Phillips NA, et al.
Published: (2023-02-01)

A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
by: Guglielmo Stabile, et al.
Published: (2021-11-01)

Recurrent vaginal discharge
by: Marcos Takimura, et al.
Published: (2018-10-01)

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
by: Junko Yano, et al.
Published: (2019-03-01)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
by: Gai Ge, et al.
Published: (2022-07-01)

Vulvovaginal Candidiasis and its Related Factors in Diabetic Women
by: Ozra Tabatabaei Malazy, et al.
Published: (2007-12-01)

Prevalencia de resultado positivo de la citología para vaginosis bacteriana, candidiasis y tricomoniasis en una Empresa Social del Estado de Medellín (Colombia), 2010-2012
by: Jaiberth Antonio Cardona-Arias, et al.
Published: (2014-09-01)

Species composition and dynamic changes of vaginal microbiota in patients with recurrent vulvovaginal candidiasis
by: Ou Liying, Zhou Chenfei, Cai Huihua, Liu Mubiao
Published: (2022-06-01)

Changing Trends of Vulvovaginal Candidiasis
by: Doddaiah Vijaya, et al.
Published: (2014-01-01)

The Effect of use of Vaginal Lactobacillus Rhamnosus for Prevention of Recurrence of Vulvovaginal Candidiasis: A randomized controlled trial
by: Alaa M. Ismail, et al.
Published: (2017-03-01)

Phenotypic characterization and antifungal susceptibility profile of Candida isolates from women with vulvovaginal candidiasis at a community health center linked to a teaching institution in the Sub-Himalayan region of North India
by: Sangeeta Rawat, et al.
Published: (2023-01-01)